Can screening for atrial fibrillation be implemented at scale?

Europace

Volumn 18, Issue 10, 2016, Pages 1449-1451

  Lowres, Nicole ^a,b   Neubeck, Lis ^a   Freedman, Saul B ^a,b,c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ANZAC RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ATRIAL FIBRILLATION; CARDIOLOGIST; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; EDITORIAL; ELECTROCARDIOGRAPH; ELECTROCARDIOGRAPHY; GENERAL PRACTICE; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA VACCINATION; MASS SCREENING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING;

EID: 84995705015     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euw030     Document Type: Editorial

References (15)

1. Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
2. Camm AJ, Lip GYH, Caterina RD, Savelieva I, Atar D, Hohnloser SH et al. 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
3. Lamassa M, Di Carlo A, Pracucci G, Basile AM, Trefoloni G, Vanni P et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke 2001;32:392-8.
4. Benbow A, Kirchhof P, Ladwig K-H, Lobban T, Vinolas X, Goto S et al. Strike out stroke in atrial fibrillation. Atrial fibrillation-related stroke across Europe: a preventable problem. Working Group Recommendations. 2012. http://www. stopafib.org/downloads/News436-Europe-Prevent.pdf (11 November 2014, date last accessed).
5. Go AS, Hylek E, Phillips KA, Chang YH, Lori E, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5.
6. Freedman SB, Lowres N. Asymptomatic atrial fibrillation: the case for screening to prevent stroke. JAMA 2015;314:1911-2.
7. Kirchhof P, Breithardt G, Bax J, Benninger G, Blomstrom-Lundqvist C, Boriani G et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association Consensus Conference. Europace 2016;18:37-50.
8. Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J et al. Feasibility and cost effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost 2014;111:1167-76.
9. Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 2015;131:2176-84.
10. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation: a systematic review. Thromb Haemost 2013;110: 213-22.
11. Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370: 2478-86.
12. Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead ECG device during influenza vaccination. Europace 2016;18:1514-20.
13. Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One 2013;8:e63479.
14. Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 2014;16:1291-5.
15. Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace 2015;17:1023-9.